122 related articles for article (PubMed ID: 24184471)
1. Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
Kovács R; Gesztelyi R; Berényi R; Domán M; Kardos G; Juhász B; Majoros L
J Med Microbiol; 2014 Feb; 63(Pt 2):186-194. PubMed ID: 24184471
[TBL] [Abstract][Full Text] [Related]
2. Killing Rates of Caspofungin in 50 Percent Serum Correlate with Caspofungin Efficacy Against Candida albicans in a Neutropenic Murine Model.
Domán M; Kovács R; Kardos G; Gesztelyi R; Juhász B; Bozó A; Kardos T; Saleh Q; Majoros L
Curr Drug Deliv; 2016; 13(2):255-64. PubMed ID: 27146910
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation studies with caspofungin against Candida glabrata.
Domán M; Kovács R; Perlin DS; Kardos G; Gesztelyi R; Juhász B; Bozó A; Majoros L
J Med Microbiol; 2015 Sep; 64(9):998-1007. PubMed ID: 26296340
[TBL] [Abstract][Full Text] [Related]
4. Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
Kardos T; Kovács R; Kardos G; Varga I; Bozó A; Tóth Z; Nagy F; Majoros L
J Chemother; 2018 Jul; 30(4):233-239. PubMed ID: 30025501
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro and vivo efficacy of caspofungin against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.
Földi R; Kovács R; Gesztelyi R; Kardos G; Berényi R; Juhász B; Szilágyi J; Mózes J; Majoros L
Mycopathologia; 2012 Oct; 174(4):311-8. PubMed ID: 22565489
[TBL] [Abstract][Full Text] [Related]
6. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans.
Nussbaumer-Pröll A; Matzneller P; Eberl S; Zeitlinger M
Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):927-936. PubMed ID: 38483681
[TBL] [Abstract][Full Text] [Related]
8. Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.
Kovács R; Gesztelyi R; Perlin DS; Kardos G; Domán M; Berényi R; Majoros L
Mycopathologia; 2014 Oct; 178(3-4):197-206. PubMed ID: 25118874
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
[TBL] [Abstract][Full Text] [Related]
10. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
[TBL] [Abstract][Full Text] [Related]
11. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.
Pfaller MA; Diekema DJ; Ostrosky-Zeichner L; Rex JH; Alexander BD; Andes D; Brown SD; Chaturvedi V; Ghannoum MA; Knapp CC; Sheehan DJ; Walsh TJ
J Clin Microbiol; 2008 Aug; 46(8):2620-9. PubMed ID: 18579718
[TBL] [Abstract][Full Text] [Related]
12. Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
Varga I; Sóczó G; Kardos G; Majoros L
J Antimicrob Chemother; 2008 Jul; 62(1):149-52. PubMed ID: 18390882
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection].
Ortiz de la Tabla-Ducasse V; Masiá-Canuto M; Martín-González C; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2004; 22(6):328-31. PubMed ID: 15228899
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
[TBL] [Abstract][Full Text] [Related]
15. Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodology.
Szilágyi J; Földi R; Bayegan S; Kardos G; Majoros L
J Chemother; 2012 Feb; 24(1):18-25. PubMed ID: 22546720
[TBL] [Abstract][Full Text] [Related]
16. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
17. [The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time].
Cantón E; Pemán J; Romero M; Valentín A; Gobernado M
Rev Esp Quimioter; 2007 Dec; 20(4):433-41. PubMed ID: 18563217
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the correlation of caspofungin MICs and treatment outcome in murine infections by wild type strains of Candida parapsilosis.
Salas V; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):41-5. PubMed ID: 23806662
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
Berényi R; Kovács R; Domán M; Gesztelyi R; Kardos G; Juhász B; Perlin D; Majoros L
New Microbiol; 2014 Jul; 37(3):355-62. PubMed ID: 25180850
[TBL] [Abstract][Full Text] [Related]
20. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
